ORCID as entered in ROS

Select Publications
2023, 'Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study', Implementation Science, 18, http://dx.doi.org/10.1186/s13012-023-01281-4
,2023, 'Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00885-9
,2023, 'Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00844-4
,2023, 'Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob program’s ‘cascade of care’ across nine sites in New South Wales, Australia', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00850-6
,2023, 'Insights from the scale-up and implementation of the Deadly Liver Mob program across nine sites in New South Wales, Australia, according to the RE-AIM framework', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00889-5
,2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
,2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723
,2023, 'Improving understandings of trauma and alcohol and other drug-related problems: A social research agenda', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104198
,2023, 'Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104189
,2023, 'Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104142
,2023, 'Typology of laws restricting access to methadone treatment in the United States: A latent class analysis', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104141
,2023, 'Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers', Drug and Alcohol Dependence, 249, http://dx.doi.org/10.1016/j.drugalcdep.2023.109953
,2023, 'Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia', Qualitative Health Research, 33, pp. 688 - 700, http://dx.doi.org/10.1177/10497323231173788
,2023, 'Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples', Mental Health and Prevention, 30, http://dx.doi.org/10.1016/j.mhp.2023.200267
,2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137
,2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002
,2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998
,2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6
,2023, 'Factors associated with sharing equipment among people who inject drugs: The role of community attachment in harm reduction and health promotion', Drug and Alcohol Review, 42, pp. 561 - 568, http://dx.doi.org/10.1111/dar.13606
,2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959
,2023, '‘There's too much power in this number. It's freaking the whole response out’: The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia', Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.13896
,2023, 'Aboriginal young people’s perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative study', Global Public Health, 18, http://dx.doi.org/10.1080/17441692.2023.2196561
,2023, 'Child Sexual Abuse, Alcohol and Other Drug use and the Criminal Justice System: The Meanings of Trauma in Survivor Narratives for a National Royal Commission', Qualitative Health Research, 33, pp. 117 - 126, http://dx.doi.org/10.1177/10497323221144923
,2023, 'Countering ‘the moral science of biopolitics’: Understanding hepatitis C treatment ‘non-compliance’ in the antiviral era', Sociology of Health and Illness, http://dx.doi.org/10.1111/1467-9566.13712
,2023, 'Economies of resistance', Critical Public Health, http://dx.doi.org/10.1080/09581596.2023.2271140
,2023, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.13895
,2023, 'Normalising sex and resisting shame: young Aboriginal women’s views on sex and relationships in an urban setting in Australia', Journal of Youth Studies, http://dx.doi.org/10.1080/13676261.2023.2225422
,2023, 'People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study', Drug and Alcohol Review, 42, pp. 203 - 212, http://dx.doi.org/10.1111/dar.13531
,2023, 'Socioeconomic consequences of the COVID-19 pandemic for people who use drugs', Australian Journal of Social Issues, http://dx.doi.org/10.1002/ajs4.289
,2023, 'The impact of sources of stigma on health care avoidance among gay and bisexual men in Australia', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 35, pp. 663 - 671, http://dx.doi.org/10.1080/09540121.2022.2057410
,2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925
,2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
,2023, 'Yarning as a method for building sexual wellbeing among urban Aboriginal young people in Australia', Culture, Health and Sexuality, http://dx.doi.org/10.1080/13691058.2023.2258948
,2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.', J Subst Use Addict Treat, 150, pp. 209066, http://dx.doi.org/10.1016/j.josat.2023.209066
,2022, 'A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00658-w
,2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876
,2022, 'Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00619-3
,2022, 'Commentary on the harm reduction reference group of justice health and forensic mental health network and corrective services NSW, Australia', International Journal of Prisoner Health, 18, pp. 394 - 406, http://dx.doi.org/10.1108/IJPH-06-2021-0050
,2022, 'Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions', Viruses, 14, http://dx.doi.org/10.3390/v14112542
,2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246
,2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, http://dx.doi.org/10.1136/bmjgh-2022-009408
,2022, 'Hepatitis B-related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Health and Social Care in the Community, 30, pp. e5602 - e5611, http://dx.doi.org/10.1111/hsc.13986
,2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828
,2022, 'Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Journal of Viral Hepatitis, 29, pp. 968 - 975, http://dx.doi.org/10.1111/jvh.13736
,2022, 'What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review', Health and Social Care in the Community, 30, pp. e3775 - e3788, http://dx.doi.org/10.1111/hsc.14066
,2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103788
,2022, 'Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103771
,2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746
,2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543
,2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555
,